nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—CYP2E1—Pilocarpine—glaucoma	0.0687	0.11	CbGbCtD
Fluvoxamine—CYP2E1—Methazolamide—glaucoma	0.0464	0.074	CbGbCtD
Fluvoxamine—CYP1A1—Clonidine—glaucoma	0.0434	0.0692	CbGbCtD
Fluvoxamine—CYP2D6—Carteolol—glaucoma	0.0432	0.0689	CbGbCtD
Fluvoxamine—CYP1A2—Betaxolol—glaucoma	0.0354	0.0565	CbGbCtD
Fluvoxamine—CYP2D6—Betaxolol—glaucoma	0.0292	0.0465	CbGbCtD
Fluvoxamine—CYP2C19—Methazolamide—glaucoma	0.0291	0.0464	CbGbCtD
Fluvoxamine—CYP2C9—Diclofenamide—glaucoma	0.0281	0.0448	CbGbCtD
Fluvoxamine—CYP2C9—Dorzolamide—glaucoma	0.0271	0.0433	CbGbCtD
Fluvoxamine—CYP3A5—Clonidine—glaucoma	0.0261	0.0416	CbGbCtD
Fluvoxamine—CYP2C19—Timolol—glaucoma	0.0247	0.0394	CbGbCtD
Fluvoxamine—CYP2C9—Methazolamide—glaucoma	0.0242	0.0386	CbGbCtD
Fluvoxamine—CYP2D6—Methazolamide—glaucoma	0.0221	0.0353	CbGbCtD
Fluvoxamine—CYP3A4—Pilocarpine—glaucoma	0.0208	0.0332	CbGbCtD
Fluvoxamine—ABCB1—Timolol—glaucoma	0.02	0.0318	CbGbCtD
Fluvoxamine—CYP1A2—Clonidine—glaucoma	0.0194	0.0309	CbGbCtD
Fluvoxamine—CYP2D6—Timolol—glaucoma	0.0188	0.03	CbGbCtD
Fluvoxamine—ABCB1—Clonidine—glaucoma	0.017	0.027	CbGbCtD
Fluvoxamine—CYP3A4—Brinzolamide—glaucoma	0.0163	0.026	CbGbCtD
Fluvoxamine—CYP2D6—Clonidine—glaucoma	0.016	0.0255	CbGbCtD
Fluvoxamine—CYP3A4—Dorzolamide—glaucoma	0.0158	0.0251	CbGbCtD
Fluvoxamine—CYP3A4—Methazolamide—glaucoma	0.0141	0.0224	CbGbCtD
Fluvoxamine—CYP3A4—Acetazolamide—glaucoma	0.0112	0.0179	CbGbCtD
Fluvoxamine—CYP3A4—Clonidine—glaucoma	0.0102	0.0162	CbGbCtD
Fluvoxamine—Arrhythmia—Betaxolol—glaucoma	0.000114	0.000343	CcSEcCtD
Fluvoxamine—Feeling abnormal—Dorzolamide—glaucoma	0.000113	0.000342	CcSEcCtD
Fluvoxamine—Decreased appetite—Pilocarpine—glaucoma	0.000113	0.000341	CcSEcCtD
Fluvoxamine—Feeling abnormal—Travoprost—glaucoma	0.000113	0.000341	CcSEcCtD
Fluvoxamine—Conjunctivitis—Timolol—glaucoma	0.000112	0.00034	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Dorzolamide—glaucoma	0.000112	0.00034	CcSEcCtD
Fluvoxamine—Alopecia—Betaxolol—glaucoma	0.000112	0.00034	CcSEcCtD
Fluvoxamine—Palpitations—Clonidine—glaucoma	0.000112	0.000339	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000112	0.000339	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Travoprost—glaucoma	0.000112	0.000338	CcSEcCtD
Fluvoxamine—Loss of consciousness—Clonidine—glaucoma	0.000112	0.000338	CcSEcCtD
Fluvoxamine—Feeling abnormal—Brinzolamide—glaucoma	0.000111	0.000337	CcSEcCtD
Fluvoxamine—Mental disorder—Betaxolol—glaucoma	0.000111	0.000337	CcSEcCtD
Fluvoxamine—Pain—Pilocarpine—glaucoma	0.000111	0.000336	CcSEcCtD
Fluvoxamine—Constipation—Pilocarpine—glaucoma	0.000111	0.000336	CcSEcCtD
Fluvoxamine—Cough—Clonidine—glaucoma	0.000111	0.000335	CcSEcCtD
Fluvoxamine—Sweating—Timolol—glaucoma	0.000111	0.000335	CcSEcCtD
Fluvoxamine—Dizziness—Apraclonidine—glaucoma	0.000111	0.000335	CcSEcCtD
Fluvoxamine—Malnutrition—Betaxolol—glaucoma	0.000111	0.000334	CcSEcCtD
Fluvoxamine—Urticaria—Dorzolamide—glaucoma	0.000109	0.00033	CcSEcCtD
Fluvoxamine—Epistaxis—Timolol—glaucoma	0.000109	0.00033	CcSEcCtD
Fluvoxamine—Abdominal pain—Dorzolamide—glaucoma	0.000109	0.000328	CcSEcCtD
Fluvoxamine—Body temperature increased—Dorzolamide—glaucoma	0.000109	0.000328	CcSEcCtD
Fluvoxamine—Tension—Betaxolol—glaucoma	0.000109	0.000328	CcSEcCtD
Fluvoxamine—Sinusitis—Timolol—glaucoma	0.000109	0.000328	CcSEcCtD
Fluvoxamine—Dysgeusia—Betaxolol—glaucoma	0.000108	0.000328	CcSEcCtD
Fluvoxamine—Chest pain—Clonidine—glaucoma	0.000108	0.000327	CcSEcCtD
Fluvoxamine—Arthralgia—Clonidine—glaucoma	0.000108	0.000327	CcSEcCtD
Fluvoxamine—Abdominal pain—Travoprost—glaucoma	0.000108	0.000327	CcSEcCtD
Fluvoxamine—Agranulocytosis—Timolol—glaucoma	0.000108	0.000326	CcSEcCtD
Fluvoxamine—Anxiety—Clonidine—glaucoma	0.000108	0.000326	CcSEcCtD
Fluvoxamine—Asthenia—Acetazolamide—glaucoma	0.000108	0.000325	CcSEcCtD
Fluvoxamine—Dizziness—Bimatoprost—glaucoma	0.000107	0.000325	CcSEcCtD
Fluvoxamine—Nervousness—Betaxolol—glaucoma	0.000107	0.000325	CcSEcCtD
Fluvoxamine—Urticaria—Brinzolamide—glaucoma	0.000107	0.000325	CcSEcCtD
Fluvoxamine—Feeling abnormal—Pilocarpine—glaucoma	0.000107	0.000324	CcSEcCtD
Fluvoxamine—Discomfort—Clonidine—glaucoma	0.000107	0.000323	CcSEcCtD
Fluvoxamine—Vomiting—Apraclonidine—glaucoma	0.000107	0.000322	CcSEcCtD
Fluvoxamine—Muscle spasms—Betaxolol—glaucoma	0.000106	0.000322	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000106	0.000321	CcSEcCtD
Fluvoxamine—Hypersensitivity—Brimonidine—glaucoma	0.000106	0.000321	CcSEcCtD
Fluvoxamine—Dry mouth—Clonidine—glaucoma	0.000106	0.00032	CcSEcCtD
Fluvoxamine—Bradycardia—Timolol—glaucoma	0.000106	0.00032	CcSEcCtD
Fluvoxamine—Dermatitis—Apraclonidine—glaucoma	0.000106	0.000319	CcSEcCtD
Fluvoxamine—Headache—Apraclonidine—glaucoma	0.000105	0.000317	CcSEcCtD
Fluvoxamine—Confusional state—Clonidine—glaucoma	0.000105	0.000316	CcSEcCtD
Fluvoxamine—Vision blurred—Betaxolol—glaucoma	0.000104	0.000315	CcSEcCtD
Fluvoxamine—Rhinitis—Timolol—glaucoma	0.000104	0.000315	CcSEcCtD
Fluvoxamine—Oedema—Clonidine—glaucoma	0.000104	0.000314	CcSEcCtD
Fluvoxamine—Tremor—Betaxolol—glaucoma	0.000104	0.000313	CcSEcCtD
Fluvoxamine—Hallucination—Timolol—glaucoma	0.000103	0.000312	CcSEcCtD
Fluvoxamine—Asthenia—Brimonidine—glaucoma	0.000103	0.000312	CcSEcCtD
Fluvoxamine—Infection—Clonidine—glaucoma	0.000103	0.000311	CcSEcCtD
Fluvoxamine—Body temperature increased—Pilocarpine—glaucoma	0.000103	0.00031	CcSEcCtD
Fluvoxamine—Abdominal pain—Pilocarpine—glaucoma	0.000103	0.00031	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Betaxolol—glaucoma	0.000103	0.00031	CcSEcCtD
Fluvoxamine—Diarrhoea—Acetazolamide—glaucoma	0.000103	0.00031	CcSEcCtD
Fluvoxamine—Rash—Bimatoprost—glaucoma	0.000102	0.00031	CcSEcCtD
Fluvoxamine—Dermatitis—Bimatoprost—glaucoma	0.000102	0.00031	CcSEcCtD
Fluvoxamine—Oedema peripheral—Timolol—glaucoma	0.000102	0.000309	CcSEcCtD
Fluvoxamine—Anaemia—Betaxolol—glaucoma	0.000102	0.000309	CcSEcCtD
Fluvoxamine—Shock—Clonidine—glaucoma	0.000102	0.000308	CcSEcCtD
Fluvoxamine—Pruritus—Brimonidine—glaucoma	0.000102	0.000308	CcSEcCtD
Fluvoxamine—Headache—Bimatoprost—glaucoma	0.000102	0.000308	CcSEcCtD
Fluvoxamine—Nervous system disorder—Clonidine—glaucoma	0.000102	0.000307	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Clonidine—glaucoma	0.000102	0.000307	CcSEcCtD
Fluvoxamine—Hypersensitivity—Dorzolamide—glaucoma	0.000101	0.000306	CcSEcCtD
Fluvoxamine—Tachycardia—Clonidine—glaucoma	0.000101	0.000306	CcSEcCtD
Fluvoxamine—Hypersensitivity—Travoprost—glaucoma	0.000101	0.000305	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Clonidine—glaucoma	0.0001	0.000303	CcSEcCtD
Fluvoxamine—Visual impairment—Timolol—glaucoma	0.0001	0.000302	CcSEcCtD
Fluvoxamine—Malaise—Betaxolol—glaucoma	9.98e-05	0.000302	CcSEcCtD
Fluvoxamine—Nausea—Apraclonidine—glaucoma	9.96e-05	0.000301	CcSEcCtD
Fluvoxamine—Hypersensitivity—Brinzolamide—glaucoma	9.96e-05	0.000301	CcSEcCtD
Fluvoxamine—Vertigo—Betaxolol—glaucoma	9.94e-05	0.0003	CcSEcCtD
Fluvoxamine—Syncope—Betaxolol—glaucoma	9.92e-05	0.0003	CcSEcCtD
Fluvoxamine—Dizziness—Acetazolamide—glaucoma	9.92e-05	0.0003	CcSEcCtD
Fluvoxamine—Anorexia—Clonidine—glaucoma	9.89e-05	0.000299	CcSEcCtD
Fluvoxamine—Asthenia—Dorzolamide—glaucoma	9.86e-05	0.000298	CcSEcCtD
Fluvoxamine—Asthenia—Travoprost—glaucoma	9.82e-05	0.000297	CcSEcCtD
Fluvoxamine—Palpitations—Betaxolol—glaucoma	9.78e-05	0.000296	CcSEcCtD
Fluvoxamine—Pruritus—Dorzolamide—glaucoma	9.73e-05	0.000294	CcSEcCtD
Fluvoxamine—Loss of consciousness—Betaxolol—glaucoma	9.73e-05	0.000294	CcSEcCtD
Fluvoxamine—Eye disorder—Timolol—glaucoma	9.7e-05	0.000293	CcSEcCtD
Fluvoxamine—Asthenia—Brinzolamide—glaucoma	9.7e-05	0.000293	CcSEcCtD
Fluvoxamine—Hypotension—Clonidine—glaucoma	9.69e-05	0.000293	CcSEcCtD
Fluvoxamine—Pruritus—Travoprost—glaucoma	9.68e-05	0.000293	CcSEcCtD
Fluvoxamine—Tinnitus—Timolol—glaucoma	9.68e-05	0.000293	CcSEcCtD
Fluvoxamine—Cough—Betaxolol—glaucoma	9.66e-05	0.000292	CcSEcCtD
Fluvoxamine—Nausea—Bimatoprost—glaucoma	9.66e-05	0.000292	CcSEcCtD
Fluvoxamine—Cardiac disorder—Timolol—glaucoma	9.64e-05	0.000291	CcSEcCtD
Fluvoxamine—Hypersensitivity—Pilocarpine—glaucoma	9.57e-05	0.000289	CcSEcCtD
Fluvoxamine—Pruritus—Brinzolamide—glaucoma	9.56e-05	0.000289	CcSEcCtD
Fluvoxamine—Vomiting—Acetazolamide—glaucoma	9.54e-05	0.000288	CcSEcCtD
Fluvoxamine—Dizziness—Brimonidine—glaucoma	9.52e-05	0.000288	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Clonidine—glaucoma	9.45e-05	0.000286	CcSEcCtD
Fluvoxamine—Angiopathy—Timolol—glaucoma	9.42e-05	0.000285	CcSEcCtD
Fluvoxamine—Arthralgia—Betaxolol—glaucoma	9.42e-05	0.000285	CcSEcCtD
Fluvoxamine—Chest pain—Betaxolol—glaucoma	9.42e-05	0.000285	CcSEcCtD
Fluvoxamine—Myalgia—Betaxolol—glaucoma	9.42e-05	0.000285	CcSEcCtD
Fluvoxamine—Diarrhoea—Dorzolamide—glaucoma	9.41e-05	0.000284	CcSEcCtD
Fluvoxamine—Headache—Acetazolamide—glaucoma	9.4e-05	0.000284	CcSEcCtD
Fluvoxamine—Anxiety—Betaxolol—glaucoma	9.39e-05	0.000284	CcSEcCtD
Fluvoxamine—Insomnia—Clonidine—glaucoma	9.38e-05	0.000284	CcSEcCtD
Fluvoxamine—Diarrhoea—Travoprost—glaucoma	9.36e-05	0.000283	CcSEcCtD
Fluvoxamine—Asthenia—Pilocarpine—glaucoma	9.32e-05	0.000282	CcSEcCtD
Fluvoxamine—Paraesthesia—Clonidine—glaucoma	9.31e-05	0.000282	CcSEcCtD
Fluvoxamine—Discomfort—Betaxolol—glaucoma	9.31e-05	0.000281	CcSEcCtD
Fluvoxamine—Arrhythmia—Timolol—glaucoma	9.28e-05	0.00028	CcSEcCtD
Fluvoxamine—Dyspnoea—Clonidine—glaucoma	9.25e-05	0.00028	CcSEcCtD
Fluvoxamine—Diarrhoea—Brinzolamide—glaucoma	9.25e-05	0.000279	CcSEcCtD
Fluvoxamine—Somnolence—Clonidine—glaucoma	9.22e-05	0.000279	CcSEcCtD
Fluvoxamine—Dry mouth—Betaxolol—glaucoma	9.21e-05	0.000278	CcSEcCtD
Fluvoxamine—Pruritus—Pilocarpine—glaucoma	9.19e-05	0.000278	CcSEcCtD
Fluvoxamine—Alopecia—Timolol—glaucoma	9.18e-05	0.000277	CcSEcCtD
Fluvoxamine—Confusional state—Betaxolol—glaucoma	9.11e-05	0.000275	CcSEcCtD
Fluvoxamine—Mental disorder—Timolol—glaucoma	9.1e-05	0.000275	CcSEcCtD
Fluvoxamine—Dizziness—Dorzolamide—glaucoma	9.09e-05	0.000275	CcSEcCtD
Fluvoxamine—Rash—Brimonidine—glaucoma	9.08e-05	0.000274	CcSEcCtD
Fluvoxamine—Dermatitis—Brimonidine—glaucoma	9.07e-05	0.000274	CcSEcCtD
Fluvoxamine—Dizziness—Travoprost—glaucoma	9.05e-05	0.000274	CcSEcCtD
Fluvoxamine—Malnutrition—Timolol—glaucoma	9.04e-05	0.000273	CcSEcCtD
Fluvoxamine—Oedema—Betaxolol—glaucoma	9.03e-05	0.000273	CcSEcCtD
Fluvoxamine—Headache—Brimonidine—glaucoma	9.02e-05	0.000273	CcSEcCtD
Fluvoxamine—Decreased appetite—Clonidine—glaucoma	9.02e-05	0.000273	CcSEcCtD
Fluvoxamine—Infection—Betaxolol—glaucoma	8.97e-05	0.000271	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Clonidine—glaucoma	8.96e-05	0.000271	CcSEcCtD
Fluvoxamine—Fatigue—Clonidine—glaucoma	8.94e-05	0.00027	CcSEcCtD
Fluvoxamine—Dizziness—Brinzolamide—glaucoma	8.94e-05	0.00027	CcSEcCtD
Fluvoxamine—Nausea—Acetazolamide—glaucoma	8.91e-05	0.000269	CcSEcCtD
Fluvoxamine—Diarrhoea—Pilocarpine—glaucoma	8.89e-05	0.000269	CcSEcCtD
Fluvoxamine—Shock—Betaxolol—glaucoma	8.88e-05	0.000269	CcSEcCtD
Fluvoxamine—Tension—Timolol—glaucoma	8.87e-05	0.000268	CcSEcCtD
Fluvoxamine—Constipation—Clonidine—glaucoma	8.87e-05	0.000268	CcSEcCtD
Fluvoxamine—Pain—Clonidine—glaucoma	8.87e-05	0.000268	CcSEcCtD
Fluvoxamine—Nervous system disorder—Betaxolol—glaucoma	8.86e-05	0.000268	CcSEcCtD
Fluvoxamine—Dysgeusia—Timolol—glaucoma	8.85e-05	0.000268	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Betaxolol—glaucoma	8.84e-05	0.000267	CcSEcCtD
Fluvoxamine—Tachycardia—Betaxolol—glaucoma	8.81e-05	0.000266	CcSEcCtD
Fluvoxamine—Nervousness—Timolol—glaucoma	8.78e-05	0.000265	CcSEcCtD
Fluvoxamine—Vomiting—Dorzolamide—glaucoma	8.74e-05	0.000264	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Betaxolol—glaucoma	8.73e-05	0.000264	CcSEcCtD
Fluvoxamine—Rash—Dorzolamide—glaucoma	8.67e-05	0.000262	CcSEcCtD
Fluvoxamine—Dermatitis—Dorzolamide—glaucoma	8.66e-05	0.000262	CcSEcCtD
Fluvoxamine—Rash—Travoprost—glaucoma	8.63e-05	0.000261	CcSEcCtD
Fluvoxamine—Dermatitis—Travoprost—glaucoma	8.62e-05	0.000261	CcSEcCtD
Fluvoxamine—Headache—Dorzolamide—glaucoma	8.61e-05	0.00026	CcSEcCtD
Fluvoxamine—Anorexia—Betaxolol—glaucoma	8.61e-05	0.00026	CcSEcCtD
Fluvoxamine—Vomiting—Brinzolamide—glaucoma	8.59e-05	0.00026	CcSEcCtD
Fluvoxamine—Dizziness—Pilocarpine—glaucoma	8.59e-05	0.00026	CcSEcCtD
Fluvoxamine—Headache—Travoprost—glaucoma	8.57e-05	0.000259	CcSEcCtD
Fluvoxamine—Nausea—Brimonidine—glaucoma	8.55e-05	0.000258	CcSEcCtD
Fluvoxamine—Feeling abnormal—Clonidine—glaucoma	8.55e-05	0.000258	CcSEcCtD
Fluvoxamine—Rash—Brinzolamide—glaucoma	8.52e-05	0.000258	CcSEcCtD
Fluvoxamine—Vision blurred—Timolol—glaucoma	8.52e-05	0.000258	CcSEcCtD
Fluvoxamine—Dermatitis—Brinzolamide—glaucoma	8.51e-05	0.000257	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Clonidine—glaucoma	8.48e-05	0.000256	CcSEcCtD
Fluvoxamine—Headache—Brinzolamide—glaucoma	8.47e-05	0.000256	CcSEcCtD
Fluvoxamine—Hypotension—Betaxolol—glaucoma	8.44e-05	0.000255	CcSEcCtD
Fluvoxamine—Angioedema—Timolol—glaucoma	8.26e-05	0.00025	CcSEcCtD
Fluvoxamine—Vomiting—Pilocarpine—glaucoma	8.26e-05	0.00025	CcSEcCtD
Fluvoxamine—Urticaria—Clonidine—glaucoma	8.24e-05	0.000249	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Betaxolol—glaucoma	8.23e-05	0.000249	CcSEcCtD
Fluvoxamine—Abdominal pain—Clonidine—glaucoma	8.2e-05	0.000248	CcSEcCtD
Fluvoxamine—Body temperature increased—Clonidine—glaucoma	8.2e-05	0.000248	CcSEcCtD
Fluvoxamine—Rash—Pilocarpine—glaucoma	8.19e-05	0.000248	CcSEcCtD
Fluvoxamine—Dermatitis—Pilocarpine—glaucoma	8.18e-05	0.000247	CcSEcCtD
Fluvoxamine—Insomnia—Betaxolol—glaucoma	8.17e-05	0.000247	CcSEcCtD
Fluvoxamine—Nausea—Dorzolamide—glaucoma	8.17e-05	0.000247	CcSEcCtD
Fluvoxamine—Headache—Pilocarpine—glaucoma	8.14e-05	0.000246	CcSEcCtD
Fluvoxamine—Nausea—Travoprost—glaucoma	8.13e-05	0.000246	CcSEcCtD
Fluvoxamine—Vertigo—Timolol—glaucoma	8.12e-05	0.000245	CcSEcCtD
Fluvoxamine—Paraesthesia—Betaxolol—glaucoma	8.11e-05	0.000245	CcSEcCtD
Fluvoxamine—Syncope—Timolol—glaucoma	8.11e-05	0.000245	CcSEcCtD
Fluvoxamine—Dyspnoea—Betaxolol—glaucoma	8.05e-05	0.000243	CcSEcCtD
Fluvoxamine—Nausea—Brinzolamide—glaucoma	8.03e-05	0.000243	CcSEcCtD
Fluvoxamine—Palpitations—Timolol—glaucoma	7.99e-05	0.000241	CcSEcCtD
Fluvoxamine—Dyspepsia—Betaxolol—glaucoma	7.95e-05	0.00024	CcSEcCtD
Fluvoxamine—Loss of consciousness—Timolol—glaucoma	7.95e-05	0.00024	CcSEcCtD
Fluvoxamine—Cough—Timolol—glaucoma	7.89e-05	0.000238	CcSEcCtD
Fluvoxamine—Decreased appetite—Betaxolol—glaucoma	7.85e-05	0.000237	CcSEcCtD
Fluvoxamine—Hypertension—Timolol—glaucoma	7.8e-05	0.000236	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Betaxolol—glaucoma	7.8e-05	0.000236	CcSEcCtD
Fluvoxamine—Fatigue—Betaxolol—glaucoma	7.79e-05	0.000235	CcSEcCtD
Fluvoxamine—Pain—Betaxolol—glaucoma	7.72e-05	0.000233	CcSEcCtD
Fluvoxamine—Constipation—Betaxolol—glaucoma	7.72e-05	0.000233	CcSEcCtD
Fluvoxamine—Nausea—Pilocarpine—glaucoma	7.72e-05	0.000233	CcSEcCtD
Fluvoxamine—Chest pain—Timolol—glaucoma	7.7e-05	0.000233	CcSEcCtD
Fluvoxamine—Myalgia—Timolol—glaucoma	7.7e-05	0.000233	CcSEcCtD
Fluvoxamine—Arthralgia—Timolol—glaucoma	7.7e-05	0.000233	CcSEcCtD
Fluvoxamine—Anxiety—Timolol—glaucoma	7.67e-05	0.000232	CcSEcCtD
Fluvoxamine—Hypersensitivity—Clonidine—glaucoma	7.64e-05	0.000231	CcSEcCtD
Fluvoxamine—Discomfort—Timolol—glaucoma	7.6e-05	0.00023	CcSEcCtD
Fluvoxamine—Dry mouth—Timolol—glaucoma	7.53e-05	0.000227	CcSEcCtD
Fluvoxamine—Asthenia—Clonidine—glaucoma	7.44e-05	0.000225	CcSEcCtD
Fluvoxamine—Feeling abnormal—Betaxolol—glaucoma	7.44e-05	0.000225	CcSEcCtD
Fluvoxamine—Confusional state—Timolol—glaucoma	7.44e-05	0.000225	CcSEcCtD
Fluvoxamine—Oedema—Timolol—glaucoma	7.38e-05	0.000223	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Timolol—glaucoma	7.38e-05	0.000223	CcSEcCtD
Fluvoxamine—Pruritus—Clonidine—glaucoma	7.34e-05	0.000222	CcSEcCtD
Fluvoxamine—Infection—Timolol—glaucoma	7.33e-05	0.000222	CcSEcCtD
Fluvoxamine—Shock—Timolol—glaucoma	7.26e-05	0.000219	CcSEcCtD
Fluvoxamine—Nervous system disorder—Timolol—glaucoma	7.23e-05	0.000219	CcSEcCtD
Fluvoxamine—Urticaria—Betaxolol—glaucoma	7.17e-05	0.000217	CcSEcCtD
Fluvoxamine—Body temperature increased—Betaxolol—glaucoma	7.14e-05	0.000216	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Timolol—glaucoma	7.13e-05	0.000216	CcSEcCtD
Fluvoxamine—Diarrhoea—Clonidine—glaucoma	7.1e-05	0.000215	CcSEcCtD
Fluvoxamine—Anorexia—Timolol—glaucoma	7.03e-05	0.000213	CcSEcCtD
Fluvoxamine—Hypotension—Timolol—glaucoma	6.89e-05	0.000208	CcSEcCtD
Fluvoxamine—Dizziness—Clonidine—glaucoma	6.86e-05	0.000207	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Timolol—glaucoma	6.72e-05	0.000203	CcSEcCtD
Fluvoxamine—Insomnia—Timolol—glaucoma	6.67e-05	0.000202	CcSEcCtD
Fluvoxamine—Hypersensitivity—Betaxolol—glaucoma	6.65e-05	0.000201	CcSEcCtD
Fluvoxamine—Paraesthesia—Timolol—glaucoma	6.62e-05	0.0002	CcSEcCtD
Fluvoxamine—Vomiting—Clonidine—glaucoma	6.6e-05	0.000199	CcSEcCtD
Fluvoxamine—Dyspnoea—Timolol—glaucoma	6.58e-05	0.000199	CcSEcCtD
Fluvoxamine—Somnolence—Timolol—glaucoma	6.56e-05	0.000198	CcSEcCtD
Fluvoxamine—Rash—Clonidine—glaucoma	6.54e-05	0.000198	CcSEcCtD
Fluvoxamine—Dermatitis—Clonidine—glaucoma	6.53e-05	0.000198	CcSEcCtD
Fluvoxamine—Headache—Clonidine—glaucoma	6.5e-05	0.000196	CcSEcCtD
Fluvoxamine—Dyspepsia—Timolol—glaucoma	6.49e-05	0.000196	CcSEcCtD
Fluvoxamine—Asthenia—Betaxolol—glaucoma	6.48e-05	0.000196	CcSEcCtD
Fluvoxamine—Decreased appetite—Timolol—glaucoma	6.41e-05	0.000194	CcSEcCtD
Fluvoxamine—Pruritus—Betaxolol—glaucoma	6.39e-05	0.000193	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Timolol—glaucoma	6.37e-05	0.000193	CcSEcCtD
Fluvoxamine—Fatigue—Timolol—glaucoma	6.36e-05	0.000192	CcSEcCtD
Fluvoxamine—Pain—Timolol—glaucoma	6.31e-05	0.000191	CcSEcCtD
Fluvoxamine—Diarrhoea—Betaxolol—glaucoma	6.18e-05	0.000187	CcSEcCtD
Fluvoxamine—Nausea—Clonidine—glaucoma	6.16e-05	0.000186	CcSEcCtD
Fluvoxamine—Feeling abnormal—Timolol—glaucoma	6.08e-05	0.000184	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Timolol—glaucoma	6.03e-05	0.000182	CcSEcCtD
Fluvoxamine—Dizziness—Betaxolol—glaucoma	5.97e-05	0.000181	CcSEcCtD
Fluvoxamine—Urticaria—Timolol—glaucoma	5.86e-05	0.000177	CcSEcCtD
Fluvoxamine—Body temperature increased—Timolol—glaucoma	5.83e-05	0.000176	CcSEcCtD
Fluvoxamine—Abdominal pain—Timolol—glaucoma	5.83e-05	0.000176	CcSEcCtD
Fluvoxamine—Vomiting—Betaxolol—glaucoma	5.74e-05	0.000174	CcSEcCtD
Fluvoxamine—Rash—Betaxolol—glaucoma	5.69e-05	0.000172	CcSEcCtD
Fluvoxamine—Dermatitis—Betaxolol—glaucoma	5.69e-05	0.000172	CcSEcCtD
Fluvoxamine—Headache—Betaxolol—glaucoma	5.66e-05	0.000171	CcSEcCtD
Fluvoxamine—CYP2C9—Biological oxidations—GSTT1—glaucoma	5.65e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.63e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NARFL—glaucoma	5.63e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CA5A—glaucoma	5.63e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NARFL—glaucoma	5.61e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CA5A—glaucoma	5.61e-05	0.00134	CbGpPWpGaD
Fluvoxamine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	5.61e-05	0.00134	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	5.59e-05	0.00133	CbGpPWpGaD
Fluvoxamine—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	5.45e-05	0.0013	CbGpPWpGaD
Fluvoxamine—Hypersensitivity—Timolol—glaucoma	5.44e-05	0.000164	CcSEcCtD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	5.43e-05	0.00129	CbGpPWpGaD
Fluvoxamine—Nausea—Betaxolol—glaucoma	5.36e-05	0.000162	CcSEcCtD
Fluvoxamine—CYP1A1—Metabolism—CA5A—glaucoma	5.3e-05	0.00126	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NARFL—glaucoma	5.3e-05	0.00126	CbGpPWpGaD
Fluvoxamine—Asthenia—Timolol—glaucoma	5.29e-05	0.00016	CcSEcCtD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor—TNF—glaucoma	5.27e-05	0.00125	CbGpPWpGaD
Fluvoxamine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	5.27e-05	0.00125	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase II conjugation—GSTM1—glaucoma	5.25e-05	0.00125	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—GSTM1—glaucoma	5.22e-05	0.00124	CbGpPWpGaD
Fluvoxamine—Pruritus—Timolol—glaucoma	5.22e-05	0.000158	CcSEcCtD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	5.19e-05	0.00124	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	5.15e-05	0.00123	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GSTM1—glaucoma	5.11e-05	0.00122	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—glaucoma	5.1e-05	0.00121	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GSTM1—glaucoma	5.1e-05	0.00121	CbGpPWpGaD
Fluvoxamine—Diarrhoea—Timolol—glaucoma	5.05e-05	0.000153	CcSEcCtD
Fluvoxamine—CYP2E1—Metapathway biotransformation—GSTM1—glaucoma	5.04e-05	0.0012	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	5.03e-05	0.0012	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	4.98e-05	0.00118	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	4.93e-05	0.00117	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—glaucoma	4.88e-05	0.00116	CbGpPWpGaD
Fluvoxamine—Dizziness—Timolol—glaucoma	4.88e-05	0.000147	CcSEcCtD
Fluvoxamine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	4.87e-05	0.00116	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GSTT1—glaucoma	4.82e-05	0.00115	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GSTM1—glaucoma	4.82e-05	0.00115	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—GSTM1—glaucoma	4.75e-05	0.00113	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	4.71e-05	0.00112	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	4.71e-05	0.00112	CbGpPWpGaD
Fluvoxamine—Vomiting—Timolol—glaucoma	4.69e-05	0.000142	CcSEcCtD
Fluvoxamine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	4.66e-05	0.00111	CbGpPWpGaD
Fluvoxamine—Rash—Timolol—glaucoma	4.65e-05	0.000141	CcSEcCtD
Fluvoxamine—Dermatitis—Timolol—glaucoma	4.65e-05	0.00014	CcSEcCtD
Fluvoxamine—Headache—Timolol—glaucoma	4.62e-05	0.00014	CcSEcCtD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.61e-05	0.0011	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	4.54e-05	0.00108	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP1B1—glaucoma	4.5e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	4.48e-05	0.00107	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	4.44e-05	0.00106	CbGpPWpGaD
Fluvoxamine—Nausea—Timolol—glaucoma	4.38e-05	0.000132	CcSEcCtD
Fluvoxamine—CYP2C19—Metabolism—CA5A—glaucoma	4.34e-05	0.00103	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NARFL—glaucoma	4.34e-05	0.00103	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CA5A—glaucoma	4.24e-05	0.00101	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NARFL—glaucoma	4.24e-05	0.00101	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.2e-05	0.001	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—TNF—glaucoma	4.18e-05	0.000996	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	4.05e-05	0.000964	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NARFL—glaucoma	3.99e-05	0.00095	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CA5A—glaucoma	3.99e-05	0.00095	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CA5A—glaucoma	3.96e-05	0.000942	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NARFL—glaucoma	3.96e-05	0.000942	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.94e-05	0.000939	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	3.92e-05	0.000933	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.89e-05	0.000926	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	3.84e-05	0.000915	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CA1—glaucoma	3.79e-05	0.000903	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	3.79e-05	0.000903	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.73e-05	0.000889	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.72e-05	0.000886	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.71e-05	0.000883	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.68e-05	0.000876	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CTSA—glaucoma	3.67e-05	0.000874	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GSTM1—glaucoma	3.63e-05	0.000864	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.6e-05	0.000856	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.59e-05	0.000855	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	3.58e-05	0.000852	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	3.55e-05	0.000844	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CA2—glaucoma	3.47e-05	0.000826	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.47e-05	0.000825	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA5A—glaucoma	3.38e-05	0.000805	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NARFL—glaucoma	3.38e-05	0.000805	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	3.36e-05	0.0008	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	3.36e-05	0.0008	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—VEGFA—glaucoma	3.19e-05	0.000758	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	3.17e-05	0.000756	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.07e-05	0.000732	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.03e-05	0.000722	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—TP53—glaucoma	3.01e-05	0.000717	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.97e-05	0.000706	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.93e-05	0.000697	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CA1—glaucoma	2.8e-05	0.000668	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CA1—glaucoma	2.75e-05	0.000654	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CA1—glaucoma	2.74e-05	0.000653	CbGpPWpGaD
Fluvoxamine—ABCB1—Allograft Rejection—TNF—glaucoma	2.73e-05	0.00065	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CTSA—glaucoma	2.72e-05	0.000647	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.71e-05	0.000646	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CTSA—glaucoma	2.66e-05	0.000633	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CTSA—glaucoma	2.66e-05	0.000632	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NARFL—glaucoma	2.61e-05	0.000621	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA5A—glaucoma	2.61e-05	0.000621	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CA1—glaucoma	2.59e-05	0.000617	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CA2—glaucoma	2.57e-05	0.000611	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.54e-05	0.000604	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CA2—glaucoma	2.51e-05	0.000598	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CTSA—glaucoma	2.51e-05	0.000597	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CA2—glaucoma	2.51e-05	0.000597	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—TXN—glaucoma	2.44e-05	0.000582	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.37e-05	0.000565	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CA2—glaucoma	2.37e-05	0.000564	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.34e-05	0.000557	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.32e-05	0.000551	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.32e-05	0.000551	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CA1—glaucoma	2.12e-05	0.000505	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CA1—glaucoma	2.07e-05	0.000492	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CTSA—glaucoma	2.05e-05	0.000489	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CTSA—glaucoma	2e-05	0.000477	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	2e-05	0.000475	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CA1—glaucoma	1.95e-05	0.000464	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CA2—glaucoma	1.94e-05	0.000461	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CA1—glaucoma	1.93e-05	0.00046	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTT1—glaucoma	1.89e-05	0.000451	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.89e-05	0.000451	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.89e-05	0.000451	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CA2—glaucoma	1.89e-05	0.00045	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.89e-05	0.00045	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CTSA—glaucoma	1.89e-05	0.000449	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CTSA—glaucoma	1.87e-05	0.000446	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—TXN—glaucoma	1.81e-05	0.00043	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CA2—glaucoma	1.78e-05	0.000424	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—TXN—glaucoma	1.77e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CA2—glaucoma	1.77e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—TXN—glaucoma	1.77e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.73e-05	0.000411	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.73e-05	0.000411	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—TXN—glaucoma	1.67e-05	0.000397	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA1—glaucoma	1.65e-05	0.000393	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CTSA—glaucoma	1.6e-05	0.000381	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.57e-05	0.000374	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.52e-05	0.000363	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CA2—glaucoma	1.51e-05	0.00036	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ABCA1—glaucoma	1.51e-05	0.000359	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP1B1—glaucoma	1.51e-05	0.000359	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.51e-05	0.000359	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.48e-05	0.000351	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.48e-05	0.000351	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTT1—glaucoma	1.4e-05	0.000334	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTT1—glaucoma	1.37e-05	0.000327	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTT1—glaucoma	1.37e-05	0.000326	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—TXN—glaucoma	1.37e-05	0.000325	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.35e-05	0.000321	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—TXN—glaucoma	1.33e-05	0.000317	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTT1—glaucoma	1.29e-05	0.000308	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA1—glaucoma	1.27e-05	0.000303	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—TXN—glaucoma	1.26e-05	0.000299	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.25e-05	0.000297	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—TXN—glaucoma	1.25e-05	0.000296	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.23e-05	0.000294	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CTSA—glaucoma	1.23e-05	0.000294	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GSTM1—glaucoma	1.21e-05	0.000287	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	1.19e-05	0.000283	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CA2—glaucoma	1.17e-05	0.000278	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.14e-05	0.000271	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.13e-05	0.000268	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP1B1—glaucoma	1.12e-05	0.000266	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ABCA1—glaucoma	1.12e-05	0.000266	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ABCA1—glaucoma	1.09e-05	0.00026	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CYP1B1—glaucoma	1.09e-05	0.00026	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ABCA1—glaucoma	1.09e-05	0.00026	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP1B1—glaucoma	1.09e-05	0.00026	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MTHFR—glaucoma	1.07e-05	0.000254	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—TXN—glaucoma	1.06e-05	0.000253	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTT1—glaucoma	1.06e-05	0.000252	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.04e-05	0.000248	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTT1—glaucoma	1.03e-05	0.000246	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ABCA1—glaucoma	1.03e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP1B1—glaucoma	1.03e-05	0.000245	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—APOE—glaucoma	9.93e-06	0.000236	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CAV1—glaucoma	9.84e-06	0.000234	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTT1—glaucoma	9.74e-06	0.000232	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.71e-06	0.000231	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTT1—glaucoma	9.66e-06	0.00023	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.62e-06	0.000229	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GSTM1—glaucoma	8.93e-06	0.000213	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GSTM1—glaucoma	8.74e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GSTM1—glaucoma	8.72e-06	0.000208	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.54e-06	0.000203	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ABCA1—glaucoma	8.44e-06	0.000201	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP1B1—glaucoma	8.44e-06	0.000201	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTT1—glaucoma	8.25e-06	0.000196	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GSTM1—glaucoma	8.24e-06	0.000196	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ABCA1—glaucoma	8.24e-06	0.000196	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP1B1—glaucoma	8.24e-06	0.000196	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—TXN—glaucoma	8.21e-06	0.000196	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MTHFR—glaucoma	7.89e-06	0.000188	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.79e-06	0.000185	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ABCA1—glaucoma	7.76e-06	0.000185	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP1B1—glaucoma	7.76e-06	0.000185	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MTHFR—glaucoma	7.73e-06	0.000184	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MTHFR—glaucoma	7.71e-06	0.000184	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ABCA1—glaucoma	7.69e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP1B1—glaucoma	7.69e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—NOS3—glaucoma	7.44e-06	0.000177	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—APOE—glaucoma	7.34e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MTHFR—glaucoma	7.28e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CAV1—glaucoma	7.28e-06	0.000173	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—APOE—glaucoma	7.19e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—APOE—glaucoma	7.18e-06	0.000171	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—CAV1—glaucoma	7.13e-06	0.00017	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CAV1—glaucoma	7.11e-06	0.000169	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—PTGS2—glaucoma	6.8e-06	0.000162	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—APOE—glaucoma	6.78e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GSTM1—glaucoma	6.75e-06	0.000161	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CAV1—glaucoma	6.72e-06	0.00016	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.65e-06	0.000158	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GSTM1—glaucoma	6.58e-06	0.000157	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ABCA1—glaucoma	6.57e-06	0.000157	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP1B1—glaucoma	6.57e-06	0.000157	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTT1—glaucoma	6.37e-06	0.000152	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GSTM1—glaucoma	6.2e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GSTM1—glaucoma	6.15e-06	0.000146	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MTHFR—glaucoma	5.96e-06	0.000142	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MTHFR—glaucoma	5.82e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—APOE—glaucoma	5.55e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—NOS3—glaucoma	5.5e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CAV1—glaucoma	5.5e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MTHFR—glaucoma	5.48e-06	0.000131	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MTHFR—glaucoma	5.44e-06	0.000129	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—APOE—glaucoma	5.42e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—NOS3—glaucoma	5.39e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—NOS3—glaucoma	5.38e-06	0.000128	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CAV1—glaucoma	5.37e-06	0.000128	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GSTM1—glaucoma	5.26e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—APOE—glaucoma	5.1e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—NOS3—glaucoma	5.08e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP1B1—glaucoma	5.07e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ABCA1—glaucoma	5.07e-06	0.000121	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—APOE—glaucoma	5.06e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CAV1—glaucoma	5.06e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—PTGS2—glaucoma	5.03e-06	0.00012	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CAV1—glaucoma	5.01e-06	0.000119	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—PTGS2—glaucoma	4.93e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—PTGS2—glaucoma	4.92e-06	0.000117	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—PTGS2—glaucoma	4.65e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MTHFR—glaucoma	4.64e-06	0.000111	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—APOE—glaucoma	4.32e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CAV1—glaucoma	4.28e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—NOS3—glaucoma	4.16e-06	9.9e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—NOS3—glaucoma	4.06e-06	9.66e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GSTM1—glaucoma	4.06e-06	9.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—NOS3—glaucoma	3.82e-06	9.1e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—PTGS2—glaucoma	3.8e-06	9.05e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—NOS3—glaucoma	3.79e-06	9.03e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—PTGS2—glaucoma	3.71e-06	8.84e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MTHFR—glaucoma	3.58e-06	8.53e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—PTGS2—glaucoma	3.5e-06	8.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—PTGS2—glaucoma	3.47e-06	8.25e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—APOE—glaucoma	3.34e-06	7.95e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CAV1—glaucoma	3.31e-06	7.87e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—NOS3—glaucoma	3.24e-06	7.71e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—PTGS2—glaucoma	2.96e-06	7.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—NOS3—glaucoma	2.5e-06	5.95e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—PTGS2—glaucoma	2.29e-06	5.44e-05	CbGpPWpGaD
